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Background: The NuRD complex controls gene expression through altering chromatin structure.
Results: The MTA1-RbAp48 structure shows how the RbAp46/p48 histone chaperones are recruited to NuRD.
Conclusion: The MTA subunits act as scaffolds for NuRD complex assembly.
Significance: TheMTA/RbAp48 interaction prevents binding of histone H4, which is crucial for understanding the role of the
RbAp46/p48 chaperones in the complex.
The nucleosome remodeling and deacetylase (NuRD) com-
plex is a widely conserved transcriptional co-regulator that har-
bors both nucleosome remodeling and histone deacetylase
activities. It plays a critical role in the early stages of ES cell
differentiation and the reprogramming of somatic to induced
pluripotent stem cells. Abnormalities in several NuRD proteins
are associated with cancer and aging. We have investigated the
architecture ofNuRDbydetermining the structure of a subcom-
plex comprising RbAp48 andMTA1. Surprisingly, RbAp48 rec-
ognizes MTA1 using the same site that it uses to bind histone
H4, showing that assembly into NuRD modulates RbAp46/48
interactions with histones. Taken together with other results,
our data show that the MTA proteins act as scaffolds for NuRD
complex assembly. We further show that the RbAp48-MTA1
interaction is essential for the in vivo integration of RbAp46/48
into the NuRD complex.
In eukaryotes, chromatin structure is modulated by multi-
protein enzymes such as the nucleosome remodeling and
deacetylase (NuRD) complex.8 NuRD can both activate and
repress transcription (1–3), and it is essential for embryonic
development in complex organisms (4). It also plays a role in
DNA damage repair (5), and the silencing of NuRD compo-
nents leads to changes in chromatin structure that mimic aging
(6).
In mammals, the NuRD complex consists of 10 proteins
that are consistently observed during purification. CHD4 (Mi-
2) is an ATP-dependent helicase that can reposition nucleo-
somes (7). HDAC1 and HDAC2 remove acetyl groups from
lysine residues and are associated with gene repression (8).
GATAD2A and GATAD2B (p66/p66) are potent transcrip-
tional repressors (9, 10) but are otherwise poorly characterized,
whereasMBD2 andMBD3, which appear to bemutually exclu-
sive in NuRD, contain methyl CpG binding domains (11–13).
MBD3 has been shown to play a key role in suppressing pluri-
potency in early development (14, 15).
RbAp46 and RbAp48 (RBBP7/RBBP4) are 50-kDa WD-
repeat proteins (16, 17) that were first recognized for their abil-
ity to bind the tumor suppressor Rb (18). A role for RbAp48 as
a mediator of age-related memory loss has also recently been
reported (19). RbAp46 and RbAp48 together with HDAC1 and
HDAC2 have been proposed to form a core deacetylase com-
plex (20) that is common to both the NuRD and Sin3 com-
plexes. RbAp46 and RbAp48 are also found in other gene reg-
ulatory complexes, such as NURF (nucleosome remodeling
factor) (21) and PRC2 (polycomb repressive complex 2) (22).
MTA1, MTA2, and MTA3 are highly related proteins that
contain several well conserved structured domains at their N
termini (Fig. 1). Their C-terminal regions are less conserved
and are predicted to be largely disordered. MTA1 is one of the
most up-regulated genes in human cancers and is particularly
associatedwithmetastatic and aggressive tumors andwith poor
prognosis (23–25).
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Despite its central importance in development, very little is
known about the architecture of the NuRD complex, how it
assembles, and which combinations of the components form
stable complexes. There are three-dimensional structures
available for two intact subunits, namely RbAp46/48 (16, 17)
and HDAC2/HDAC1 (26, 27). There are also structures of iso-
lated domains, including the PHD domains (28) and one chro-
modomain (PDB code 2EE1) of CHD4, the methyl-DNA bind-
FIGURE 1. Sequence alignment of MTA1, MTA2, and MTA3 from various eukaryotes. The alignment was produced using the ALINE program (64). Well
defined domains are indicated. Uniprot accession numbers are: human MTA1 (Q13330), mouse MTA1 (Q8K4B0), rat MTA1 (Q62599), frog MTA1 (F6YJW8), fly
MTA1 (Q9VNF6), humanMTA2 (O94776),mouseMTA2 (Q9R190), ratMTA2 (B2GV01), frogMTA2 (Q4V7T0), humanMTA3 (Q9BTC8),mouseMTA3 (Q924K8) and
bovine MTA3 (A6QL72). The KRAARRmotif is boxed in gray.
Structure of an RbAp48-MTA1 Complex
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ing domain of MBD2 (29) and the SANT domain of MTA3
(PDB code 2CRG). Although many intersubunit interactions
have been reported (30), these data are almost exclusively lim-
ited to GST pulldown and co-immunoprecipitation assays.
However, there are structures of the 40-residue coiled-coil
formed betweenMBD2 andGATAD2A (31) as well as, notably,
of the ELM2-SANT domain of MTA1 bound to HDAC1 (27).
Here we show that the MTA proteins also recruit the histone
chaperones RbAp46/48, suggesting that MTA1/2/3 act as a
scaffold in NuRD. Moreover, our structure of the MTA1-
RbAp48 complex shows that the interaction of MTA subunits
with RbAp46/48 modulates binding of histones H3-H4, a sub-
strate of the complex.
EXPERIMENTAL PROCEDURES
Plasmid Construction—FLAG-tagged human RbAp48 (Uni-
prot: Q09028) was constructed by PCR and cloned into
pcDNA3. MTA1 constructs (residues 1–250, 230–550, and
530–715) were generated by PCR amplification of the human
gene (Uniprot: Q13330) and cloned into pcDNA3. MTA1 con-
structs (residues 530–635, 625–715, 643–695, and 656–686)
were created by PCR amplification from codon-optimized
sequences for bacterial expression (GenScript) and cloned into
pGEX-6P with an N-terminal GST tag.
Protein Production for Biochemical/Structural Analysis—
pcDNA3 constructs were expressed in vitro in the presence of
[35S]methionine. GST-MTA1 constructs were expressed in the
BL21 strain of Escherichia coli and inducedwith 0.4mM isopro-
pyl 1-thio--D-galactopyranoside. The culture was incubated
with shaking at 25 °C overnight, and the protein was subse-
quently purified by glutathione affinity chromatography. GST-
H4-(1–48) was expressed and purified by glutathione affinity
chromatography as described previously (16). Recombinant
RbAp48 was expressed and purified from insect cells as
described previously (17).
Peptide Synthesis—All MTA1 peptides used here were syn-
thesized and purified (to 95% purity) by ChinaPeptides (Shang-
hai, China) with acetyl- and amide-capping groups at the N-
and C-terminal ends, respectively.
Pulldown Assays—RbAp48 and MTA1 constructs were in
vitro translated in the presence of 35S-labeledmethionine using
the TNT Quick Coupled Transcription/Translation kit (Pro-
mega) according to the manufacturer’s instructions. In vitro
translated 35S-labeled FLAG-RbAp48 (20 l) was immobilized
onto agarose beads conjugated to anti-FLAG (M2) antibodies
(Sigma) in binding buffer (50 mM Tris, pH 7.5, 300 mM NaCl,
0.5% Triton X-100, complete protease inhibitor mixture tablet
(Roche Applied Science), and 1 mM DTT). The mixture was
incubatedwith in vitro translated 35S-labeled-MTA1 fragments
(40 l) at 4 °C for 2 h. The beads were then washed five times
with binding buffer. Anti-FLAG beads alone were used as a
negative control. Complexes were resolved by SDS-PAGE and
visualized by autoradiography.
GST pulldown assays were performed by incubating equal
amounts of GST or GST-MTA1 fusion proteins immobilized
on glutathione-Sepharose beads (Amersham Biosciences) with
in vitro translated 35S-labeled RbAp48. The mixtures were
incubated for 2 h at 4 °C and washed 5 times with binding
buffer. Complexes were resolved by SDS-PAGE and visualized
by autoradiography.
Isothermal Titration Calorimetry (ITC)—ITCmeasurements
were carried out at 25 °C using a MicroCal iTC200 titration
calorimeter. RbAp48 and MTA1 peptides were dialyzed sepa-
rately overnight against a buffer containing 20mMTris, pH 7.5,
and 150 mM NaCl. The MTA1 peptide (250 M) was titrated
into RbAp48 (25 M, 200 l) in a series of 20 (2 l) injections
with a 2.5-min interval between each injection. The reference
power was set to 2 cal/s, and the cell was stirred continuously
at 1000 rpm. The evolved heats were integrated and normalized
for protein concentration. After base-line correction (using
data from the titration of the MTA1 peptide into buffer), the
data were fitted to a simple single-site binding model using the
MicroCal Origin 7.0 software package.
Crystallization and Structure Determination—MTA1 pep-
tides (comprising residues 656–686, 670–695, and 670–711)
were dissolved in 50 mM Tris, pH 8.0. Concentrated RbAp48
protein (5 mg/ml) was mixed with MTA1 peptide at a molar
ratio of 1:4. Co-crystallization trials were set up in 96-well
plates as sitting drops using either anOryx6 protein crystalliza-
tion robot (Douglas Instruments) orNanodropMosquito robot
and commercial crystallization screens (Morpheus (Gorrec
2009) and NeXtalDWBlocks, Qiagen). Crystals grew in 1–2
days at 18 °C in several conditions. X-ray datawere collected for
the RbAp48-MTA1-(656–686) complex from single crystals
obtained in 10% w/v polyethylene glycol (PEG) 20,000, 20% v/v
polyethylene glycol monomethyl ether 550, 0.2 M 1,6-hexane-
diol, 0.2 M 1-butanol, 0.2 M (RS)-1,2-propanediol, 0.2 M 2-pro-
panol, 0.2 M 1,4-butanediol, 0.2 M 1,3-propanediol, and 0.1 M
MES/imidazole, pH 6.5. For the RbAp48-MTA1-(670–695)
complex, data were collected from crystals obtained in 12.5%
w/v PEG 1000, 12.5% w/v PEG 3350, 12.5% v/v 2-methyl-2,4-
pentanediol, 0.2 M 1,6-hexanediol, 0.2 M 1-butanol, 0.2 M (RS)-
1,2-propanediol, 0.2 M 2-propanol, 0.2 M 1,4-butanediol, 0.2 M
1,3-propanediol, and 0.1 M MES/imidazole pH 6.5. Crystals of
RbAp48-MTA1-(670–711) grew in 0.2 M calcium acetate and
20% w/v PEG 3350. Crystals were harvested in mother liquor
before cryogenic cooling in liquid nitrogen. All crystals were
cryo-protected with the addition of 25% glycerol. Diffraction
data were collected at the Diamond Light Source beamline I04
(for crystals of RbAp48-MTA1-(656–686)/(670–695)) and
using an in-house rotating copper anode generator (for crystals
of RbAp48-MTA1-(670–711)). Datawere processed and scaled
usingMOSFLM (32) and Scala (33). The structures were solved
by molecular replacement with the program Phaser (34) using
RbAp48 as the search model (PDB code 2XU7). Models were
built with Coot (35) and refined using Refmac (36). MolProbity
(37) was used to validate each structure, and the EBI PISA
server (38) was used for interface analysis.
The atomic coordinates and structure factors for the com-
plexes of RbAp48 bound to MTA1-(656–686), MTA1-(670–
695) and MTA1-(670–711) have been deposited into the
Protein Data Bank (PDB entries 4PBY, 4PBZ, and 4PC0,
respectively).
Expression and Affinity Purification of Protein A- and GFP-
tagged Complexes from Drosophila melanogaster Cells—Full-
length Nurf55 (also known as p55 and CAF1) is theD. melano-
Structure of an RbAp48-MTA1 Complex
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gaster homolog of RbAp46/p48. It was PCR-amplified and
cloned into the pDONR221 vector via the BP (recombination
and insertion of the att B sequence into the att P recombination
site) reaction using standard Gateway Technology (Invitrogen)
protocols. Five residues in this plasmid were mutated (L35Y,
E361Q, D362N, E364Q, D365N) to create pDONR-Nurf55mut
using the QuikChange Lightning Site-directedMutagenesis kit
(Agilent Technologies). The resulting wild-type and mutant
clones were verified by sequencing. Primer sequences for
the constructs are available on request. The Nurf55 genes were
then transferred into destination vectors for the inducible
expression of protein A- or GFP-tagged fusion proteins by the
LR (insertion of sequences containing att L sites into destina-
tion att R sites) reaction according to the manufacturer’s
instructions.
D. melanogaster Dmel-2 cell lines stably expressing either
tagged wild-type or mutant Nurf55 (containing the L35Y,
E361Q, D362N, E364Q, and D365N mutations) were estab-
lished. Affinity purification of protein A- and GFP-tagged bait
and interacting proteins followed bymass spectrometry identi-
fication was carried out as previously reported (39–41).
RESULTS
AShortMotif at theC-terminal End ofMTA-1BindsRbAp48—
To delineate the RbAp48 binding region of MTA1, we gener-
ated a series of in vitro translated N- and C-terminal trunca-
tions of MTA1 and carried out pulldown experiments using in
vitro translated FLAG-RbAp48 as bait. N-terminal constructs
encompassing the BAH, ELM2, SANT, and ZF domains of
MTA1 did not interact with RbAp48 (Figs. 2,A and B), whereas
the C-terminal portion of MTA1 was robustly pulled down.
Pulldown experiments using additional deletion constructs
(Fig. 2C) indicated that MTA1-(656–686) was sufficient to
bind RbAp48. Comparison of this sequence with those of other
RbAp48/RbAp46-binding proteins revealed a short motif
(678KRAARR683) that resembles part of the RbAp48/RbAp46
binding motif of histone H4 (16, 42). In histone H4, this motif
adopts a helical conformation when bound to RbAp46. As
MTA1(665–682) was also predicted to be helical, we won-
dered whether it might have a similar binding mode.
Crystal Structures of RbAp48 Bound toMTA1 Peptides—The
shortest fragment of MTA1 capable of pulling down in vitro
translated RbAp48 was MTA1-(656–686) (Fig. 2), and so to
understand the mode of binding we crystallized a complex of
RbAp48 bound to MTA1-(656–686) (Fig. 3). Diffraction data
were collected to 2.50 Å resolution and indexed in the space
group P21. Phases were obtained by molecular replacement
using the structure of RbAp48 (PDB code 2XU7) as a search
model (17). MTA1 was clearly detectable in the histone H4
binding site on RbAp48 in an mFo  DFc difference map. The
KRAARR motif of the MTA1 peptide was observed, but resi-
dues N-terminal to this sequence (656–672) did not give clear
electron density, suggesting that they were not ordered. We,
therefore crystallized two further RbAp48-MTA1 complexes,
where theN terminus of eachMTA1peptidewas defined by the
structurally resolved region in our initial complex (residue 670).
We extended the C terminus of each MTA peptide (either to
residue 695 or 711) to explore the extent of the structured seg-
ment and collected diffraction data to 2.15 Å and 2.50 Å reso-
lution, respectively. Two molecules of RbAp48 and two mole-
cules of MTA1 were found in the asymmetric unit of crystals
formed from the complexes of RbAp48 and MTA1-(656–686
and 670–711), whereas one molecule of each polypeptide was
observed in the asymmetric unit of RbAp48-MTA1-(670–
695). Rcryst and Rfree for each of the final refined models were,
respectively, 18.2% and 22.5% for RbAp48-MTA1-(656–686),
18.9% and 23.1% for RbAp48-MTA1-(670–695), and 20.6%
and 25.9% for RbAp48-MTA1-(670–711). The statistics for
data collection and refinement are listed in Table 1.
The conformations of RbAp48 were essentially identical
across all three structures (rootmean square deviation of 0.21Å
pairwise over 311 C atoms; Fig. 3). RbAp48 has the seven-
bladed -propeller fold common to all WD40-repeat proteins
but also displays three non-canonical features: an extended
loop (the PP loop; Ref. 16) inserted into blade 6, a long addi-
FIGURE 2.Mapping the region of MTA1 that binds RbAp48. A, schematic of the MTA1 constructs used in pulldown assays. B, pulldown assays using in vitro
translated 35S-labeled FLAG-RbAp48 immobilized on anti-FLAG beads and in vitro translated 35S-labeledMTA1 constructs. Input is 10% of the amount used in
each pulldown. A sample containing beads alone served as a negative control. Reactionswere analyzed by SDS-PAGE and autoradiography. C, left hand panel,
pulldown assays using in vitro translated 35S-labeled RbAp48 pulled down by bacterially expressed GST fusions of MTA1 fragments loaded onto glutathione-
Sepharosebeads. Input (i) refers to10%of theamountof RbAp48used ineachpulldown, and thenegative control (ve) containsGSTalone loadedontobeads.
Protein (p) refers to RbAp48 protein that is pulled down in each case. Right hand panel: Coomassie blue-stained SDS-PAGE indicating the amount of either GST
or GST-MTA1 (constructs 4 and 5) used.
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tional N-terminal -helix that contacts blades 6 and 7, and a
single turn of C-terminal helix after blade 7. Our structures
reveal that the MTA1 peptide binds in an amphipathic -heli-
cal conformation in the groove on RbAp48 formed by these
three structural elements (Fig. 3). As predicted by its sequence
similarity with histone H4, the basic residues in the MTA1
FIGURE 3. X-ray crystal structures of RbAp48-MTA1-(656–686), RbAp48-MTA1-(670–695), and RbAp48-MTA1-(670–711). A, ribbon diagram showing
a superposition of RbAp48-MTA1-(656–686), RbAp48-MTA1-(670–695), and RbAp48-MTA1-(670–711) over all C atoms. RbAp48 is shown in green, red, and
gold, and the MTA1 peptides are shown in brown, yellow, and blue, respectively. The blades of RbAp48 are labeled numerically. B, surface/schematic view of
RbAp48-MTA1-(670–695), indicating the elements of the RbAp48 structure that are contacted byMTA1. The structure is rotated 90° in the indicated direction
relative to the orientation in part A. C, detail of the RbAp48-MTA1-(670–695) structure showing interactionsmade by the basic side chains of MTA1. Here, the
structure is rotated 120° relative to its orientation in part A.D, hydrophobic interactions formed in the complex. Residues from RbAp48 are shown as red sticks,
and MTA1 is shown in yellow.
TABLE 1
Crystallographic and refinement statistics for the RbAp48/MTA1 complexes
r.m.s.d., root mean square deviation; I, intensity; ChirVolume, chiral volume.
RbAp48-MTA1-(656–686) RbAp48-MTA1-(670–695) RbAp48-MTA1-(670–711)
Data Collection
Space group P21 P21 P21
Unit cell dimensions
a, b, c (Å) 81.56, 59.48, 104.63 61.80, 59.82, 68.07 52.25, 123.23, 87.34
, ,  (°) 90.00, 90.12, 90.00 90.00, 99.19, 90.00 90.00, 103.39, 90.00
Resolution (Å) 52.31-2.50 (2.64-2.50) 33.60-2.15 (2.21-2.15) 61.61-2.50 (2.64-2.50)
Rmerge (%) 12.2 (44.8) 4.7 (49.7) 9.50 (35.7)
No. of observations 122,920 (18,058) 94,637 (4,598) 234,305 (33,787)
Mean [(I)/S.D. (I)] 10.6 (2.4) 13.0 (2.1) 11.9 (3.8)
Completeness (%) 99.6 (99.8) 97.3 (80.8) 91.1 (100.0)
Multiplicity 3.5 (3.6) 3.6 (2.9) 6.9 (6.3)
Refinement
Resolution (Å) 20.00-2.50 20.00-2.15 20.00-2.50
No. of reflections 33,113 24,747 32,008
Rwork/Rfree 0.182/0.225 0.189/0.231 0.206/0.259
r.m.s.d. values
Bond length (Å) 0.011 0.013 0.006
Bond angles (°) 1,432 1,494 1,041
ChirVolume 0.082 0.087 0.061
No of atoms 6,768 3,378 7,094
B-factor 25.49 61.13 33.57
Ramachandran values (%)
Most favored 95.0 95.8 97.0
Additionally allowed 4.5 3.9 2.8
Outliers 0.5 0.3 0.2
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KRAARR motif make very similar hydrogen bonding and salt
bridge contacts with this acidic groove (Fig. 3C). Residues Lys-
678/Arg-682 and Arg-679/Arg-683 of MTA1 make analogous
contacts to those formed with residues Arg-35/Arg-39 and
Arg-36/Arg-40 of histone H4, respectively (Fig. 4A). The pres-
ence of electron density from theMTA1 sequence KRAARR in
all three structures strongly suggests that this motif is critical
for the interaction between RbAp48 and MTA1.
MTA1-(670–695) Has a Higher Affinity for RbAp48 Than
Does MTA1-(656–686) or MTA1-(670–711)—As expected,
pulldown experiments with point mutants confirmed that the
KRAARR motif is essential for RbAp48 recognition by MTA1
(data not shown). We also confirmed the importance of this
motif using isothermal titration calorimetry. In all cases the
data fitted well to a simple 1:1 binding isotherm, and dissocia-
tion constants from representative measurements were 2.3 
0.3, 0.05  0.007, and 0.24  0.16 M for MTA1-(656–686),
MTA1-(670–695), and MTA1-(670–711), respectively (Fig. 5;
standard errors from single curve fits are given). The structures
provide a rationale for the higher affinity observed for the
MTA1-(670–695) and MTA1-(670–711) peptides as com-
pared with MTA1-(656–686). As shown in Fig. 3D, residues
Ile-688 and Leu-690 form a hydrophobic cluster with Leu-672.
This cluster, which cannot form in the MTA1-(656–686) pep-
tide, interacts with the aromatic side chain of Phe-30 in
RbAp48. It is not clear at this stage, however, why the affinity of
RbAp48 for the MTA1-(670–711) peptide is apparently lower
than that for MTA1-(670–695); the interactions made in both
crystal structures are essentially identical. Our data show that
the extreme C terminus of the protein (Leu-696–Asp-715) is
not required for the interaction.
MTA1andHistoneH3/FOG1Bind Independently toRbAp48—
The structural data provide clear evidence that histone H4 and
MTA1 bind mutually exclusively to RbAp48. We previously
solved the structure of a complex formed by RbAp48 and a
peptide (residues 1–15) derived from the co-regulator FOG1
(17), demonstrating that the peptide binds in an extended con-
formation to a groove on one face of the RbAp48 -propeller
(Fig. 4C). Schmitges et al. (43) showed that the N-terminal tail
of histoneH3 binds toNurf55 in a very similar fashion to FOG1
(Fig. 4C) (Nurf55, also known as p55 and CAF1, is the sole
D. melanogaster homolog of RbAp46/RbAp48; see Fig. 6).
Competition-binding experiments were performed to assess
whether full-length MTA1 might inhibit the interaction of
RbAp48 with H3 or FOG1 peptides and to confirm that H4 and
MTA1 bind mutually exclusively to RbAp48. GST-H4-(1–48)
FIGURE 4.Comparisonof theRbAp48-MTA1 structurewithother RbAp46/48 complex structures.A, comparison of interactionsmadebyhistoneH4-(28–
42) (PDB 3CFS, salmon) andMTA1-(670–695) (yellow) with RbAp46 (16) and RbAp48, respectively. Residues inMTA1 andH4 thatmake intermolecular contacts
are shown as sticks. All of the interactions made by histone H4 are observed in the MTA1 structure. Key interacting residues of MTA1 together with the
correspondingH4 residues are labeled.B, comparisonof interactionsmadebySu(z)12-(79–91) (PDB2YB8,magenta; Ref. 43) andMTA1-(670–695) (yellow)with
Nurf55 and RbAp48, respectively. Residues inMTA1 and Su(z)12 thatmake intermolecular contacts are shown as sticks. C, comparison of interactionsmade by
H3-(2–20) (PDB code 2YB8, orange; Ref. 43) and FOG-1-(1–15) (PDB code 2XU7, cyan; Ref. 17) with Nurf55 and RbAp48, respectively. D, overlay of RbAp46/48/
Nurf55-MTA1/H4/Su(z)12/H3/FOG-1 complex structures. In all parts, RbAp48 is shown as a gray surface.
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was expressed in bacteria, immobilized onto glutathione beads,
and used to pull down RbAp48 in the absence and presence of
full-length MTA1 (Fig. 7A). In a complementary experiment
(Fig. 7B), in vitro translated FLAG-RbAp48was immobilized on
anti-FLAG beads and used to pull down MTA1 in the absence
and presence of histone H4-(1–48). These data support the
conclusion that histone H4 and MTA1 compete for the same
binding surface on RbAp48. To examine whether MTA1 can
also inhibit interactions with either histone H3 or FOG1, a
competition experiment was performed by adding increasing
amounts of FOG1-(1–15) peptide to a complex comprising full-
length MTA1 and FLAG-RbAp48 immobilized on anti-FLAG
beads (Fig. 7). In this experiment the FOG1 peptide was unable
to interfere with the MTA1-RbAp48 interaction. The same
result was observed using only a C-terminal MTA1 fragment
(residues 530–715) that includes the KRAARRmotif identified
above. Thus, it is likely that the interaction of MTA1 with
RbAp48 does not affect the interactions with either histone H3
or FOG1.
The KRAARR BindingMotif Is Required for the Interaction of
RbAp48 with NuRD in Vivo—Next, we sought to determine
whether RbAp48 and MTA1 interact in the same way in vivo,
and, if so, whether the interaction of RbAp48 with the NuRD
complex is affected when the RbAp48-MTA1 interaction we
have identified is abolished. To this end, we studied the simpler
D. melanogaster NuRD in which each protein has only a single
isoform. All components bear a high degree of sequence simi-
larity to their mammalian counterparts, rendering this a good
model for the mammalian NuRD complex.
Nurf55 has previously been crystallized in complex with a
peptide from histone H4, and this structure is in close agree-
ment with that of RbAp46 bound to the same peptide (16, 44,
45). We designed a version of Nurf55 in which residues lining
theMTA1/histone H4 binding pocket were mutated. Cell lines
stably expressing protein A-tagged fusion proteins of either
wild-type Nurf55 or the mutant (Nurf55mut) were generated.
RbAp46 shares 90 and 85% sequence identity with RbAp48
and NuRF55, respectively. We previously demonstrated that
when RbAp46 is mutated within its charged PP loop (E356Q,
D357N, E359Q, and D360N) and within the hydrophobic sur-
face of helix 1 (L30Y), these collective mutations abrogate its
interaction with histone GST-tagged H4 (residues 1–48; Ref
16). We, therefore, made analogous changes to the Nurf55
binding pocket (E361Q, D362N, E364Q, D365N, and L35Y) to
similarly disrupt the interaction of Nurf55 with H4/MTA1.
GFP-tagged versions of these proteins were used to confirm
that they share the same subcellular localization as the endog-
enous protein (data not shown). We also confirmed that the
Nurf55/Nurf55mut fusion proteins were expressed at endoge-
nous levels (Fig. 8). Cellular proteins that interact with protein
A-taggedNurf55/Nurf55mut were then isolated by affinity puri-
fication on IgG beads and identified by mass spectrometry as
described previously (39, 40).
All of the known subunits of the D. melanogaster NuRD
complex (MTA-like, MBD-like, Rpd3 (dHDAC), and Mi-2
(dCHD)), were pulled down by Nurf55, whereas the equivalent
interactions with Nurf55mut were not observed (see Table 2).
We also identified Simjang and CG18292 as possible Drosoph-
ila homologs of the mammalian GATAD2A/2B (p66/p66)
and CDK2AP (DOC1 (46)) proteins, respectively. To confirm
these results we carried out a second experiment in which cel-
lular proteins that interact with GFP-taggedNurf55/Nurf55mut
were isolated by affinity purification on beads to which a
recombinant anti-GFP nanobody had been covalently attached
(41). This experiment allowedmore efficient purification of the
complex and thus better coverage of tryptic peptides from the
Mi-2, Rpd3, Simjang, and CG18292 proteins with wild-type
Nurf55. However, once again the numbers of NuRD complex
peptides detectedwith theNurf55mutantwere reduced greatly
(see Table 2), confirming that disruption of the RbAp48-MTA1
interface we identified abolishes the association of RbAp48
with the NuRD complex. These data underscore the in vivo
importance of the RbAp48-MTA1 interaction we identified for
the association of RbAp48 with the NuRD complex.
DISCUSSION
The RbAp48-MTA1 Interaction Is Highly Conserved—Previ-
ous studies using GST pulldown assays have mapped the
domains that mediate the interaction between MTA1/2 and
RbAp46/48. Roche et al. (47) showed that the predictedGATA-
type zinc finger domain of MTA1 (residues 392–448) is suffi-
cient to recognize RbAp46/48, and Fu et al. (48) reported that
RbAp46 could interact with any of three non-overlapping con-
FIGURE 5. Measurement of the binding affinities of MTA1 peptides for
RbAp48 by ITC. A, ITC profile for binding of an MTA1-(656–686) peptide to
RbAp48. B, ITC profile for binding of an MTA1-(670–695) peptide to RbAp48.
Simulated curves for affinities of 0.016 and 0.15 M are shown to provide an
indication of the reliability of the fit. C, ITC profile for binding of an MTA1-
(670–711) peptide to RbAp48. In all cases datawere fitted to a one-sitemodel
with a stoichiometry of 1:1. Titrations were carried out at 25 °C, and the data
were fitted using Origin 7.0 and a standard 1:1 bindingmodel (solid black line
in the lower panel). Each titration was carried out in duplicate.
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structs from the C-terminal portion of MTA2; only one of
these constructs, however, contained the predicted zinc fin-
ger. Our crystallographic and biochemical data reveal that a
short motif near the C-terminal end of MTA1 is able to bind
independently to RbAp48. Specifically, residues 672–688
of MTA1 adopt a conformation that includes a short
amphipathic -helix, binding in a distinct pocket formed by
three helical elements of RbAp48. Although the apparent
inconsistency between these different studies remains unre-
solved, it is worth noting that GST pulldown assays can give
FIGURE 6. Sequence alignment of theWD40proteins RbAp48 and RbAp46 fromHomo sapiens,Musmusculus, and Xenopus tropicaliswithD. melano-
gaster (Nurf55). Secondary structure (with reference to RbAp48) is denoted by arrows (-strands) and cylinders (-helices), and the MTA1 (squares) and H4
binding residues (triangles) are indicated.
FIGURE 7. Histone H3/FOG1 and MTA1 do not compete for binding to
RbAp48. A, pulldown showing the binding of in vitro translated 35S-la-
beled RbAp48 to GST-histone H4-(1–48) (immobilized on glutathione
beads) in the absence and presence of in vitro translated MTA1. B, pull-
down showing the binding of in vitro translated 35S-labeled MTA1 to
FLAG-RbAp48 (immobilized on anti-FLAG beads) in the absence and pres-
ence of histone H4-(1–48). C, pulldown assays showing the effect of add-
ing increasing amounts of FOG1-(1–15) peptide to a complex formed
between in vitro translated 35S-labeled FLAG-RbAp48 (immobilized on
anti-FLAG beads) and in vitro translated 35S-labeled full-length MTA1 or
MTA1-(530–715). The input (i) lane contains 10% of the 35S-labeled
RbAp48, full-length MTA1, and MTA1-(530–715) proteins used in pull-
down assays. The positive control (ve) is 35S-labeled FLAG-RbAp48 and
MTA1 without the FOG1-(1–15) peptide, and anti-FLAG beads plus MTA1
alone was used as the negative control (ve).
FIGURE 8. A comparison of endogenous and protein A-tagged Nurf55.
Western blot analysis to compare the expression levels of stably expressed
protein A-tagged and endogenous Nurf55 in D. melanogaster Dmel-2 cells
using an anti-p55/dCAF1 (ab1766) antibody at 1:5000 dilution.
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rise to false positive interactions if the domain fused to GST
is not correctly folded (49, 50).
Despite the apparent divergence of the C-terminal regions of
theMTA proteins (e.g. there is 34% sequence similarity for res-
idues 431–715 of human MTA1/2 compared with 74% for res-
idues 1–430), inspection of the amino acid sequences of
MTA2/MTA3andRbAp46 indicates that these proteins should
be able to substitute for MTA1 and RbAp48, respectively, to
form analogous interactions (Figs. 1 and 6). Furthermore, a
comparison of the sequences of related proteins from diverse
organisms that are predicted to contain a NuRD-like complex
(Figs. 1 and 6) suggests that this interaction is broadly con-
served. Therefore, it is likely that the interaction we have iden-
tified represents a core element of NuRD architecture across all
organisms.
The MTA1 Interaction Is Critical for RbAp48 Interactions
with theNuRDComplex—Ourmass spectrometry data probing
NuRD interactions in Drosophila cells underscore the impor-
tance of the RbAp48-MTA1 interaction on several levels. First,
the data show that theMTA1 interaction is essential for proper
assembly of RbAp48 into NuRD (in the context of the full-
length, endogenous versions of these proteins) and is conserved
across 400 million years of evolution. Second, they corrobo-
rate theMTA1-binding site that we have identified and suggest
that this binding surface is themajor (if not only) site of contact
between Nurf55 and the NuRD complex.
MTA1 and Histone H4 Compete for the Same Binding Site on
RbAp48—Our data show clearly that MTA1 and histone H4
bind to the same surface of RbAp46/48. A comparison of the
RbAp48-MTA1 and RbAp46-H4 structures shows that essen-
tially all of the intermolecular interactions made by histone H4
side chains are recapitulated in the RbAp48-MTA1 complex
(Fig. 4A). Our crystal structures suggest why the affinities of the
longer MTA1 peptides for RbAp48 are substantially higher
than those of histone H4 peptides for RbAp46 (KD of 0.05 M
for MTA1-(670–695) and 0.2 M for MTA1-(670–711) versus
1M forH4-(1–48) (16)). A tyrosine at position 685 inMTA1 is
positioned in a narrow groove on the surface of RbAp48, form-
ing van der Waals contacts with residues that line the groove,
but this residue is replaced with a glycine in histone H4.
As noted above, the RbAp46/48 proteins are found in a num-
ber of chromatin complexes, including SIN3 (51), PRC2 (22),
NURF (21), HAT1 (42), and CAF1 (52), and our results suggest
that they may play very different roles in each setting. Within
the NuRD complex the results show that RbAp46/p48-H3-H4
interactions are destabilized in the presence of MTA proteins,
but that RbAp46/p48 can still interact with histones H3-H4
through the N-terminal tail of histone H3 (43). In other words
our results suggest that competition between MTA1 and his-
tone H4 inhibits the capacity of RbAp46/48 (in the context of
NuRD) to interact with histonesH3-H4 as tightly as they would
otherwise (RbAp48 binds the histone H3-H4 complex with a
KD of 0.6 nM; Ref. 53).
Interactions between RbAp48 and Histones H3-H4 Might be
Modulated in SeveralChromatinComplexes—Inspection of the
structure of the RbAp48-MTA1 peptide complex reveals that
the binding surface on RbAp48 occupied by theMTA1 peptide
and histone H4 is also shared with Su(z)12, a component of
PRC2 (43). Interestingly, however, whereas a 12-residue pep-
tide from Su(z)12 occupies the H4/MTA1-binding site of
Nurf55, it does not form an -helix (43). The Su(z)12 backbone
has instead an irregular conformation, which nevertheless
places several residues into positions that mimic the interac-
tions made by MTA1 with RbAp48 (Fig. 4B). Thus, Su(z)12R85
occupies the same pocket as MTA1R682, and Su(z)12L87/Y89/F82
forms a hydrophobic cluster that interacts with Nurf55F34 (the
equivalent of RbAp48F30). Similarly, as shown in Fig. 4C (17,
43), FOG1 and H3 make highly conserved specific interactions
with RbAp48/Nurf55 (distinct from that of MTA1, histone H4,
and Su(z)12). The RbAp46/RbAp48/Nurf55 proteins are,
therefore, versatile interactors capable of contacting multiple
partners via the same interaction sites.
The RbAp46/48 proteins, which carry no known enzymatic
activity or nucleic acid binding capacity, act as chaperones for
histones H3-H4 in the HAT1 (42) and CAF1 (52) complexes.
The finding that both MTA1 (this work) and Su(z)12 (45) bind
in the same site as histone H4 suggests that the very tight bind-
ing of the histone H3-H4 complex by the RbAp46/48 proteins
may be also be modulated in PRC2 as well as in NuRD.
MTA Proteins Act as a Scaffold for NuRD Complex Assembly
and the Interactionwith Chromatin throughMultiple Interfaces—
When taken together with the structure of the MTA1-HDAC1
complex (27) and recent studies of MTA1/CHD4 interactions
(54), our work suggests that the MTA proteins act as a scaffold
for NuRD complex assembly, bringing together multiple pro-
teins that interact with histones, DNA, and nucleosomes (sum-
marized in Fig. 9). The dimeric MTA1 recruits, via its ELM2-
SANT domains (27), two molecules of HDAC1, which in turn
can bind and deacetylate histone H3 (55). Our results suggest
that the association of NuRD with histones H3-H4 might be
mediated (in the absence of interactions with transcriptional
co-regulators such as FOG1) by binding of RbAp46/48 to the
N-terminal tail of histone H3. Consistent with this conclusion,
MTA1 and MTA2 have both been reported to bind the N-ter-
minal tail of H3 in a manner that is inhibited by methylation of
H3K4 (54, 56). The BAH domains of several transcriptional
TABLE 2
Identification of Nurf55 interactors in D. melanogaster Dmel-2 cells
Peptides were affinity-purified using either wild type (WT) or mutated (MUT)
Nurf55-protein A (top) or Nurf55-GFP (bottom) fusion proteins as bait. For the
GFP affinity purification, each experiment was performed in triplicate, and the
lowest numbers of unique peptides derived from NuRD subunits are listed. In
the Nurf55 mutant, the following Nurf55 residues were mutated to prevent binding
to either MTA1 or H4 peptides: E361Q, D362N, E364Q, D365N, and L35Y.
Protein name
Number of peptides
identified
Nurf55WT Nurf55 MUT
Protein A affinity purification
MTA-like 57 0
MBD-like 35 0
Simjang 9 0
dMi-2 6 0
Rpd3 8 0
CG18292 (DOC1) 2 0
GFP affinity purification
MTA-like 79 6
MBD-like 22 2
Simjang 21 4
dMi-2 49 14
Rpd3 36 9
CG18292 (DOC1) 4 0
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regulators, including ORC1b (57) and CMT3 (58), have also
been demonstrated to act as histone recognition modules.
MTA1 contains an N-terminal BAH domain (Fig. 1), and this
too may be involved in nucleosome interactions. The recruit-
ment of CHD4 through MTA1 interactions also allows a num-
ber of additional contacts between NuRD and chromatin. The
PHD domains of CHD4 (and CHD3) bind nucleosomes (28,
59–61), and the PHD/chromodomains of CHD4 also regulate
the CHD4 ATPase-helicase and chromatin remodeling activity
(62, 63). It is, therefore, clear that the interactions ofNuRDwith
nucleosomes are mediated by multivalent interactions (Fig. 9).
An understanding of the interplay of these numerous NuRD-
chromatin interactions will require structural studies of the
intact NuRD complex.
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